Cell Fusion of Mesenchymal Stem/Stromal Cells and Breast Cancer Cells Leads to the Formation of Hybrid Cells Exhibiting Diverse and Individual (Stem Cell) Characteristics

by Jessica Dörnen, Ola Myklebost, Thomas Dittmar
Published 2020-12-01

Epigenetic regulation and functional characterization of microRNA-142 in mesenchymal cells.

by Magne Skårn, Tale Barøy, Eva Wessel Stratford, Ola Myklebost
Published 2013-01-01

Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas

by Sarina Gouravan, Leonardo A. Meza-Zepeda, Ola Myklebost, Eva W. Stratford, Else Munthe
Published 2018-03-01

DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation.

by Stine H Kresse, Hege O Ohnstad, Bodil Bjerkehagen, Ola Myklebost, Leonardo A Meza-Zepeda
Published 2010-01-01

Characterization of Liposarcoma Cell Lines for Preclinical and Biological Studies

by Eva W. Stratford, Russell Castro, Jeanette Daffinrud, Magne Skårn, Silje Lauvrak, Else Munthe, Ola Myklebost
Published 2012-01-01

Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines.

by Anna B Wennerström, Inger Marie Bowitz Lothe, Vandana Sandhu, Elin H Kure, Ola Myklebost, Else Munthe
Published 2014-01-01

Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene.

by Tale Barøy, Chandra S R Chilamakuri, Susanne Lorenz, Jinchang Sun, Øyvind S Bruland, Ola Myklebost, Leonardo A Meza-Zepeda
Published 2016-01-01

Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening.

by Iwona Grad, Robert Hanes, Pilar Ayuda-Durán, Marieke Lydia Kuijjer, Jorrit M Enserink, Leonardo A Meza-Zepeda, Ola Myklebost
Published 2021-01-01

Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples.

by Stine H Kresse, Heidi M Namløs, Susanne Lorenz, Jeanne-Marie Berner, Ola Myklebost, Bodil Bjerkehagen, Leonardo A Meza-Zepeda
Published 2018-01-01

Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma

by Robert Hanes, Else Munthe, Iwona Grad, Jianhua Han, Ida Karlsen, Emmet McCormack, Leonardo A. Meza-Zepeda, Eva Wessel Stratford, Ola Myklebost
Published 2019-02-01

Global Gene Expression Profiling of Human Osteosarcomas Reveals Metastasis-Associated Chemokine Pattern

by Heidi M. Namløs, Stine H. Kresse, Christoph R. Müller, Jørn Henriksen, Rita Holdhus, Gunnar Sæter, Øyvind S. Bruland, Bodil Bjerkehagen, Vidar M. Steen, Ola Myklebost
Published 2012-01-01

Modulation of the osteosarcoma expression phenotype by microRNAs.

by Heidi M Namløs, Leonardo A Meza-Zepeda, Tale Barøy, Ingrid H G Østensen, Stine H Kresse, Marieke L Kuijjer, Massimo Serra, Horst Bürger, Anne-Marie Cleton-Jansen, Ola Myklebost
Published 2012-01-01

Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.

by Stine H Kresse, Halfdan Rydbeck, Magne Skårn, Heidi M Namløs, Ana H Barragan-Polania, Anne-Marie Cleton-Jansen, Massimo Serra, Knut Liestøl, Pancras C W Hogendoorn, Eivind Hovig, Ola Myklebost, Leonardo A Meza-Zepeda
Published 2012-01-01

The expressed mutational landscape of microsatellite stable colorectal cancers

by Anita Sveen, Bjarne Johannessen, Ina A. Eilertsen, Bård I. Røsok, Marie Gulla, Peter W. Eide, Jarle Bruun, Kushtrim Kryeziu, Leonardo A. Meza-Zepeda, Ola Myklebost, Bjørn A. Bjørnbeth, Rolf I. Skotheim, Arild Nesbakken, Ragnhild A. Lothe
Published 2021-09-01

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies

by Kaja C. G. Berg, Peter W. Eide, Ina A. Eilertsen, Bjarne Johannessen, Jarle Bruun, Stine A. Danielsen, Merete Bjørnslett, Leonardo A. Meza-Zepeda, Mette Eknæs, Guro E. Lind, Ola Myklebost, Rolf I. Skotheim, Anita Sveen, Ragnhild A. Lothe
Published 2017-07-01

Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1

by Anita Sveen, Bjarne Johannessen, Torstein Tengs, Stine A. Danielsen, Ina A. Eilertsen, Guro E. Lind, Kaja C. G. Berg, Edward Leithe, Leonardo A. Meza-Zepeda, Enric Domingo, Ola Myklebost, David Kerr, Ian Tomlinson, Arild Nesbakken, Rolf I. Skotheim, Ragnhild A. Lothe
Published 2017-05-01

Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma

by Sam Behjati, Patrick S. Tarpey, Kerstin Haase, Hongtao Ye, Matthew D. Young, Ludmil B. Alexandrov, Sarah J. Farndon, Grace Collord, David C. Wedge, Inigo Martincorena, Susanna L. Cooke, Helen Davies, William Mifsud, Mathias Lidgren, Sancha Martin, Calli Latimer, Mark Maddison, Adam P. Butler, Jon W. Teague, Nischalan Pillay, Adam Shlien, Ultan McDermott, P. Andrew Futreal, Daniel Baumhoer, Olga Zaikova, Bodil Bjerkehagen, Ola Myklebost, M. Fernanda Amary, Roberto Tirabosco, Peter Van Loo, Michael R. Stratton, Adrienne M. Flanagan, Peter J. Campbell
Published 2017-06-01

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden

by Peter Peneder, Adrian M. Stütz, Didier Surdez, Manuela Krumbholz, Sabine Semper, Mathieu Chicard, Nathan C. Sheffield, Gaelle Pierron, Eve Lapouble, Marcus Tötzl, Bekir Ergüner, Daniele Barreca, André F. Rendeiro, Abbas Agaimy, Heidrun Boztug, Gernot Engstler, Michael Dworzak, Marie Bernkopf, Sabine Taschner-Mandl, Inge M. Ambros, Ola Myklebost, Perrine Marec-Bérard, Susan Ann Burchill, Bernadette Brennan, Sandra J. Strauss, Jeremy Whelan, Gudrun Schleiermacher, Christiane Schaefer, Uta Dirksen, Caroline Hutter, Kjetil Boye, Peter F. Ambros, Olivier Delattre, Markus Metzler, Christoph Bock, Eleni M. Tomazou
Published 2021-05-01